Ewing's sarcoma—Routine diagnostic utilization of MIC2 analysis: A pediatric oncology group/children's cancer group intergroup study
Open Access
- 1 March 1994
- journal article
- Published by Elsevier in Human Pathology
- Vol. 25 (3) , 304-307
- https://doi.org/10.1016/0046-8177(94)90203-8
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Comparison of Cell Surface Antigen HBA71 (p30/32MIC2), Neuron-Specific Enolase, and Vimentin in the Immunohistochemical Analysis of Ewingʼs Sarcoma of BoneThe American Journal of Surgical Pathology, 1992
- MIC2 is a specific marker for ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberrationCancer, 1991
- The E2 antigen, a 32 kd glycoprotein involved in T-cell adhesion processes, is the MIC2 gene product.The EMBO Journal, 1989
- Immunohistochemical expression of neuron-specific enolase and leu 7 in Ewing's sarcoma of boneCancer, 1989
- A Pseudoautosomal Gene in ManScience, 1986
- Cytogenetic characterization of selected small round cell tumors of childhoodCancer Genetics and Cytogenetics, 1986
- The neuroectodermal tumor of boneThe American Journal of Surgical Pathology, 1984